Cholecystokinin and panic disorder
2004 ◽
Vol 16
(2)
◽
pp. 85-93
◽
Evidence for implication of cholecystokinin (CCK) in the neurobiology of panic disorder is reviewed through animal and human pharmacological studies. The results of these investigations raise two issues: (i) selectivity of action of CCK-2 agonists in anxiety disorders; and (ii) aberrations of the CCK system in anxiety disorders, both of which are discussed.
Keyword(s):
A study on prevalence and co-morbidity of bipolar and anxiety disorders in chronic headache patients
2017 ◽
Vol 5
(7)
◽
pp. 3038
◽
1992 ◽
Vol 160
(1)
◽
pp. 57-64
◽
1986 ◽
Vol 149
(4)
◽
pp. 406-418
◽
1996 ◽
Vol 59
(3)
◽
pp. 183-188
◽